Revance Therapeutics Inc (NASDAQ:RVNC)

14.68
Delayed Data
As of Oct 15
 +0.66 / +4.67%
Today’s Change
9.88
Today|||52-Week Range
26.89
-27.10%
Year-to-Date

Today’s Trading

Previous close14.02
Today’s open14.12
Day’s range13.81 - 15.16
Volume1,217,467
Average volume (3 months)416,981
Market cap$606.4M
Data as of 3:59pm ET, 10/15/2019

Growth & Valuation

Earnings growth (last year)+1.71%
Earnings growth (this year)+9.24%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,323.28%
P/E ratioNM
Price/Sales195.26
Price/Book3.09

Competitors

 Today’s
change
Today’s
% change
KRYSKrystal Biotech Inc0.000.00%
KURAKura Oncology Inc+0.67+4.86%
KPTIKaryopharm Therapeut...+0.34+3.36%
QTRXQuanterix Corp-0.02-0.09%
Data as of 4:00pm ET, 10/15/2019

Financials

Next reporting dateNovember 11, 2019
EPS forecast (this quarter)-$0.96
Annual revenue (last year)$3.7M
Annual profit (last year)-$142.6M
Net profit margin-3,823.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Newark, California

Forecasts